CLINICAL_TRIALS
other
· 2024-05-13
Clinical Trial Update: HD21 for Advanced Stages [Phase 3]
Summary
Phase 3 clinical trial update for HD21 in advanced classical Hodgkin lymphoma; the study is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Cologne | Conditions: Classical Hodgkin Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING